We assumed that clusterin might play a protective role (as a compensatory mechanism) in psoriasis, metabolic syndrome, and other inflammatory (e.g., rheumatoid arthritis and atopic dermatitis) and neurodegenerative (e.g., Alzheimer’s and Parkinson’s) diseases. The gene discussed is CLU; the disease is atopic eczema.